These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28750489)

  • 1. Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea.
    Cho YH; Kim DH; Cha JM; Jeen YT; Moon JS; Kim JO; Lee SK; Cho YK; Im JP; Jang JY; Shin JE; Yoon SM; Jung Y; Kim ES; Lee KN; Cho SJ; Kim Y; Park BY
    Gut Liver; 2017 Nov; 11(6):821-827. PubMed ID: 28750489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.
    Bonello B; Ghanouni A; Bowyer HL; MacRae E; Atkin W; Halloran SP; Wardle J; von Wagner C
    BMC Gastroenterol; 2016 Sep; 16(1):113. PubMed ID: 27618798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea.
    Bui NC; Cho HN; Lee YY; Suh M; Park B; Jun JK; Kim Y; Choi KS
    Cancer Res Treat; 2018 Apr; 50(2):416-427. PubMed ID: 28494531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening preferences among African Americans: which screening test is preferred?
    Palmer RC; Midgette LA; Mullan ID
    J Cancer Educ; 2010 Dec; 25(4):577-81. PubMed ID: 20229075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process.
    Xu Y; Levy BT; Daly JM; Bergus GR; Dunkelberg JC
    BMC Health Serv Res; 2015 Apr; 15():175. PubMed ID: 25902770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Preferences for Colorectal Cancer Screening Tests in Light of Lowering the Screening Age to 45 Years.
    Makaroff KE; Shergill J; Lauzon M; Khalil C; Ahluwalia SC; Spiegel BMR; Almario CV
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):520-531.e10. PubMed ID: 35870766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese.
    Wong MC; Tsoi KK; Ng SS; Lou VW; Choi SY; Ling KW; Chan FK; Griffiths SM; Sung JJ
    Aliment Pharmacol Ther; 2010 Jul; 32(1):74-82. PubMed ID: 20345501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.
    Platt KD; Kurlander JE; Zikmund-Fisher BJ; Lipson R; Knaus M; Waljee AK; Saini SD
    Am J Gastroenterol; 2019 Oct; 114(10):1685-1687. PubMed ID: 31464741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender preference and implications for screening colonoscopy: impact of endoscopy nurses.
    Chong VH
    World J Gastroenterol; 2012 Jul; 18(27):3590-4. PubMed ID: 22826625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening.
    Vermeer NCA; van der Valk MJM; Snijders HS; Vasen HFA; Gerritsen van der Hoop A; Guicherit OR; Liefers GJ; van de Velde CJH; Stiggelbout AM; Peeters KCMJ
    Psychooncology; 2020 Jun; 29(6):1084-1091. PubMed ID: 32237002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case-Control Study.
    Kim SY; Kim HS; Kim YT; Lee JK; Park HJ; Kim HM; Kang DR
    Clin Transl Gastroenterol; 2021 Apr; 12(5):e00350. PubMed ID: 33928919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment.
    Heidenreich S; Finney Rutten LJ; Miller-Wilson LA; Jimenez-Moreno C; Chua GN; Fisher DA
    Cancer Med; 2022 Aug; 11(16):3156-3167. PubMed ID: 35315224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.